Back to all journals
journal articles
VIEWPOINT: DEFINING FDA APPROVED TREATMENTS AS REASONABLE AND NECESSARY: PERSPECTIVES OF INDIVIDUALS LIVING WITH ALZHEIMER’S DISEASE AND CARE PARTNERS
M.C. Carrillo, M. Moreno
J Prev Alz Dis 2023;3(10):346-348
CITATION:
M.C. Carrillo ; M. Moreno ; (2023): Viewpoint: Defining FDA Approved Treatments as Reasonable and Necessary: Perspectives of Individuals Living with Alzheimer’s Disease and Care Partners. The Journal of Prevention of Alzheimer’s Disease (JPAD). http://dx.doi.org/10.14283/jpad.2023.75